Unknown

Dataset Information

The clinical significance of RET gene fusion among Chinese patients with lung cancer.


ABSTRACT:

Background

The incidence of lung cancer is growing fast in China, however, the prognosis remains dismal due to the limited therapeutic approaches. The "ret proto-oncogene mutation" (RET) fusions have been proven to be the driver gene in lung cancer development and the therapeutic target of several multi-target tyrosine kinase inhibitors.

Methods

We applied formalin-fixed, paraffin-embedded (FFPE) samples of 39 patients with non-small cell lung cancer (NSCLC) using the Lung Plasma panel covering 168 cancer-associated genes and performed capture-based targeted deep sequencing to identify the RET fusion partners and concurrent gene mutation with Miseq. The log-rank test was used to compare the survival difference of patients according to treatment strategies. Stat

SUBMITTER: Xing P 

PROVIDER: S-EPMC8797800 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature